Evaluation of Indicators of Weight-Carrying Ability of Light Riding Horses

To answer the question of whether horse height, cannon bone circumference, and loin width can be used as indicators of weight-carrying ability in light horses, eight mature horses underwent a submaximal mounted standard exercise test under four conditions: carrying 15, 20, 25, or 30% of their body weight. Heart rate was monitored, plasma lactate concentration was determined in jugular blood samples pre-exercise, immediately post-exercise, and 10 minutes post-exercise, with serum creatine kinase activity determined at the same times as plasma lactate concentrations, with additional samples collected at 24 hours and 48 hours post-exercise. Muscle soreness and muscle tightness scores were determined using a subjective scoring system 24 hours before and 24 hours after exercise. Heart rates remained significantly higher when the horses carried 25 and 30% of their body weight. Plasma lactate concentrations immediately and 10 minutes after exercise differed when horses carried 30% of their body weight compared with 15, 20, and 25% weight carriage. Horses tended to have a greater change in muscle soreness and muscle tightness when carrying 25% of their body weight, and a significant change in soreness and tightness scores was found in horses carrying 30% of their body weight. Loin width and cannon bone circumference were found to be negatively correlated to the changes in muscle soreness and tightness scores. In conclusion, the data suggest that horses with wider loin and thicker cannon bone circumference became less sore when carrying heavier weight loads.     

肥水和打顶对薰衣草生长发育的影响

以甘肃定西栽培的一年生狭叶薰衣草（Lavandula angustifolia）为对象,探讨了施肥、浇水、打顶3种栽培管理措施对其生长发育的影响。结果表明,3种管理措施对薰衣草生长发育均有较大影响,其大小依次为浇水＞施肥＞打顶。其中,浇水和施肥具有正面影响,不仅能显著提高株高和冠幅生长量,而且能显著提高分枝数和抽穗数;打顶亦起正面作用,能显著提高分枝数,但会降低生长早期的生长量和抽穗率。两种施肥方法(沟施和撒施)对薰衣草生长发育的影响差异不显著（P>0.05）,但3种肥料类型(氮、磷、氮+磷)对其的影响差异较显著(P<0.05),其中氮肥和氮+磷混合肥的效果好于磷肥,且对薰衣草生长发育起主要促进作用的是氮肥。研究认为,水分是半干旱地区影响薰衣草生长发育的主要因子,是其栽培中的管理重点,其次是肥料,打顶为辅助管理措施。     

Relationship of Echocardiographic Measurements and Velocity at Maximum Heart Rate Measured During Prerace Training Period in Thoroughbred Horses

The objective of this study was to investigate in Thoroughbreds, the relation between the development of the heart at prerace period and the velocity at maximum heart rate (VHRmax) between the 24th and 28th month before starting to race. Twenty-one Thoroughbreds (11 female, 10 male) were used in this study. The echocardiographic data were obtained from the short-axis view in guided M-mode, at 4-month intervals until the 24th month after birth. The VHRmax was measured monthly from the 24th to the 28th month by E-Trakka. Linear regression analyses were performed between echocardiographic parameters and VHRmax values at 24 and 28 months after birth. The results indicated that left ventricular internal diameter in diastole at 12 months (LVIDD₁₂) tended to be negatively correlated with VHRmax measured at the 24th month (P = .098). However, ejection fraction (EF₁₂) (P = .061) and fractional shortening (FS₁₂) (P = .056) values tended to be positively correlated with VHRmax measured at the 24th month (VHRmax₂₄). There was a tendency toward negative correlation between interventricular septal thickening percentage (IVST%) measured 1 month after birth and VHRmax measured at the 28th month (VHRmax₂₈) (P = .079). In contrast, there were positive correlations between mean wall thickness of 4 months (MWT₄), relative wall thickness of 4 months (RWT₄), and VHRmax₂₈ (P < .05). EF₁₆ and FS₁₆ tended to be correlated with VHRmax₂₈. Furthermore, EF and FS parameters measured in 20 months after birth (EF₂₀ and FS₂₀) were correlated with VHRmax₂₈ (P < .05). There was a tendency toward a positive correlation between the left ventricular muscle mass of horses at 24 months of age (LVM₂₄) and VHRmax₂₈ (P = .097). In addition, mean wall thickness of 24 (MWT₂₄) months and relative wall thickness of 24 months (RWT₂₄) were significantly correlated with VHRmax₂₈ (P < .05). In this study, we observed a relationship between some echocardiographic parameters measured during developmental period and VHRmax measured during prerace training period. Because VHRmax is related to athletic potential, echocardiographic parameters measured at early ages may be used as selection criteria.     

Prognostic Significance of Oxidative Stress Markers in Colitis Associated with Phenylbutazone Administration in Draft Horses

The present study was carried out to assess the prognostic significance of oxidative stress markers in draft horses with colitis associated with phenylbutazone administration under field condition. For this purpose, a total of 40 native breed draft horses were studied. Based on case history, physical examination, and postmortem findings, diagnosis was made. According to the clinical outcome, horses were categorized into survivors and nonsurvivors. Clinically, there was significant association between nonsurvivors and anorexia (P < .01), stasis of intestinal motility (P < .01), melena (P < .01), and diarrhea (P < .001). Biochemically, malondialdehyde and nitric oxide showed a significant increase (P < .05) in nonsurvivors compared with survivors, whereas activities of superoxide dismutase showed a significant decrease (P < .05). Analysis of receiver operating characteristic curve indicated a high sensitivity and specificity of malondialdehyde, nitric oxide, and superoxide dismutase levels (P < .001) to predict the clinical outcome of colitis. Additionally, total protein and albumin showed a significant decrease in nonsurvivors compared with survivors; however, aspartate aminotransferase, sorbitol dehydrogenase, urea, and creatinine showed an increase (P < .05). The present results suggest that estimation of oxidative stress markers and antioxidant parameters may be useful predictors of the clinical outcomes of colitis associated with phenylbutazone administration in draft horses.     

Effect of Recovery Periods during Conditioning of Horses on Fitness Parameters

The effect of recovery from training has not been studied in horses. Therefore, the effect of recovery was examined with exercise of known effect within a conditioning period (CP). A standardized exercise test was performed at the beginning of CP to determine v₄, v₁₀, and v₁₈₀ (horse’s speed, which produced a blood lactate concentration of 4 and 10 mmol/L and a heart rate of 180 beats/min). Six horses were conditioned for three periods of 2 weeks, 5 times per fortnight at their individual v₁₀ for two bouts of 5 minutes on a treadmill. Every 2 weeks of conditioning was followed by 1 week with reduced workload. Standardized exercise test was repeated after each 2 weeks of conditioning and 2 weeks after finishing CP. Exercise speed was individually adapted to the new v₁₀ for every 2 weeks of conditioning. In addition, peak oxygen consumption before, after 3 weeks of conditioning, and at the end of the CP was measured. The mean v₄ increased steadily during CP. v₁₈₀ did not change, whereas peak oxygen consumption increased between the beginning and after 3 weeks of conditioning and leveled off thereafter. In conclusion, reducing the workload for 1 week after 2 weeks of conditioning 5 times per fortnight at v₁₀ for two bouts of 5 minutes allowed for a continuous increase of v₄, but the extent of the increase was smaller than in another study with a similar conditioning program but for the recovery week. The effect of recovery from training needs further studies.     

Population Pharmacokinetics of Tobramycin in Horses

Population pharmacokinetics of tobramycin was investigated in 28 healthy horses, with an aim to assess interindividual variability in the disposition of the antibiotic. Additionally, a covariate model for improved prediction of the concentrations in a particular animal was developed. A two-compartmental model best described the data. The final population covariate regression model was based on relationships between body weight and central and peripheral volumes of distribution, and between creatinine clearance and systemic tobramycin clearance. The value of population systemic tobramycin clearance and its interindividual variation (CV) were 0.087 L.hr⁻¹.kg⁻¹ and 6.0%, respectively. The respective values for central and peripheral volumes of distribution were 0.652 L.kg⁻¹ with CV of 17.7% and 1.56 L.kg⁻¹ with CV of 4.5%. In horses with decreased glomerular filtration rate, lower tobramycin clearance is predicted with the population model that requires administration of lower dose than that accepted for treatment of horses with normal kidney function. Population pharmacokinetic analysis allows study of basic disposition of tobramycin in horses with sparse data. The prediction power of the regression model was improved by inclusion of covariables such as body weight and creatinine clearance. This model can be used in direct patient care for the construction of dosing strategy in individual clinical cases.     

Impact of Dietary Cellobiose on the Fecal Microbiota of Horses

Cellobiose is a disaccharide with potential prebiotic effects, as demonstrated in different animal species, but not yet in horses. It was, therefore, the aim of the present study to evaluate the impact of dietary cellobiose on the fecal microbiota of horses. Eight healthy adult horses and two ponies were included in this study. The animals received a diet without or with 10 g and 20 g cellobiose per day for 14 days each. At the end of the feeding periods, fresh fecal samples were collected to measure bacterial metabolites and the microbial composition. For the microbiota analysis, 16S rRNA gene sequencing was used. Cellobiose was well accepted and tolerated by the animals. The lowest fecal concentrations of D-lactate, propionic acid, i-valeric acid, and total short-chain fatty acids were measured at the dose 10 g cellobiose per horse per day (quadratic effect: P < .05). A dose-dependent increase of the relative abundance of Firmicutes (P = .049), Coriobacteriales (P < .001), and Clostridium (P = .031) could be detected. In addition, a dose-dependent decrease of the relative abundance of Bacteroidetes (P = .035) was observed. In conclusion, the increase of Coriobacteriales and Clostridium indicates a bacterial fermentation of cellobiose in the equine intestine, as members of both groups exert saccharolytic activity. As clostridia have previously been assumed to be a key component of the intestinal microbiota in horses, the observed increase of Clostridium in the feces might indicate beneficial and potentially prebiotic effects of cellobiose in horses. However, this finding requires further investigation, particularly with regard to the Clostridium species that have been promoted by dietary cellobiose.     

Intravenous Tramadol Injection has no Antinociceptive Effect in Horses Undergoing Electrical and Thermal Stimuli

Tramadol combines an μ opiate and nonopiate analgesic mechanism and might be a useful opioid in horses. This study evaluated the effect of IV tramadol on spontaneous locomotor activity (SLA), head height, and hoof withdrawal reflex (HWR) after thermal or electrical nociceptive stimuli in horses. Doses of 2 and 3 mg/kg tramadol did not affect HWR after electrical and thermal nociception, respectively. Head height and SLA were not modified by 2, 3, or 5 mg/kg tramadol. All horses treated with 5 mg/kg tramadol developed trembling in pectoral triceps, and gluteal muscles and adopted a base-wide stance. In conclusion, 2 and 3 mg/kg tramadol IV neither induced sedation nor prolonged HWR after thermal or electrical stimuli in conscious horses. The dose of 5 mg/kg tramadol IV produced excitement, and it is apparently unsuitable for clinical use.     

Detection and Pharmacokinetics of Etoricoxib in Thoroughbred Horses

Etoricoxib, a selective inhibitor of cyclooxygenase-2, is used in the treatment of many inflammatory diseases and dental pain in humans. The aim of this study was to determine the pharmacokinetics and metabolism of etoricoxib in horses. Six horses weighing an average of 475 ± 25 kg were administered a single oral dose of etoricoxib at 1 mg/kg body weight. The results show that the drug reached a maximum concentration of 505.2 ± 67.8 ng/mL in 48 minutes after administration. The elimination half-life was calculated to be 10.20 ± 1.30 hours. Mass spectrometric analysis confirmed that etoricoxib is metabolized in horses via the oxidation of its 6′-methyl group to form a hydroxyl methyl etoricoxib which can further be oxidized to form either an acid or be glucuronidated. In addition, the 1′-N terminal of 6′-hydroxymethyl metabolite is oxidized to form the corresponding 1′-N oxide metabolite. The present results have clearly demonstrated that etoricoxib is mainly excreted in urine as metabolites. From these data, it is also possible to postulate a detection time for the metabolites which in turn can assist in the control of illegal use of the drug in horse racing.     

Voluntary Intake of Four Hay Types by Horses

Alfalfa, teff, oat, and wheat hays were fed to eight mature horses to determine voluntary intake of each hay type. After a 2-week adaptation period during which each horse was offered all four hay types each day, a 4-week study was conducted in which two horses were offered each type of hay each week, usually at the rate of 2.2% of initial body weight. Refused feed was collected and weighed the last 5 days of each week to calculate voluntary intake. Horses consumed significantly more alfalfa hay than the other hays. Wheat and teff hays were consumed in significantly lower amounts than alfalfa, but significantly more than oat hay. Across the 5 days during which voluntary intake was measured each week, hay consumption increased each day, reaching levels significantly greater than day 1 by day 4, when measured as a percentage of body weight, and day 5 when measured as a percentage of feed offered. Only alfalfa hay, at the amount consumed, met 100% of nutrient requirements for digestible energy, crude protein, lysine, calcium, and phosphorus for horses in maintenance condition. Teff hay met all nutrient requirements except digestible energy. Neither wheat nor oat hays met 100% of any of these nutrient requirements. Alfalfa and teff hays averaged about 12% nonstructural carbohydrate content (NSC), whereas wheat and oats hays contained about 30% NSC. The lower NSC content of the alfalfa and teff hays makes these more suitable for horses with problems related to carbohydrate metabolism or for refeeding starving horses.     

Pharmacokinetics of Tramadol after Epidural Administration in Horses

Tramadol is a centrally acting analgesic structurally related to codeine and morphine. The aim of the present study was to evaluate the pharmacokinetic of tramadol and its major metabolites after caudal epidural administration in the horse. Six gelding male adult horses were assigned to receive epidural administration of tramadol at 2 mg/kg. Plasma substances detection was achieved using a HPLC-FL method. Tramadol was detectable after 5 minutes up to 8 hours after epidural administration. Metabolites plasma concentrations were found under the limit of quantification of the method; however negligible amounts of M2 was detected from 30 min up to 1 hour in three subjects. In conclusion, this study shows that tramadol administered by caudal route in horses produces plasma concentrations within the extrapolated therapeutic range from humans for sufficient time to provide analgesia. Further study of the drug's safety and efficacy for the treatment of pain in horses is warranted.     

Effects of Density and Rest Stops on Movement Rates of Unrestrained Horses during Transport

The goal of this study was to provide estimates of how much loose (unrestrained) horses move during transport. Data were collected from six shipments of slaughter horses that were transported in a 16.2-m, single-deck semi-trailer in June and July of 2004 for 18 to 20 hours as part of an earlier project. Usable video was obtained from five groups of mature horses transported at “low” density (five to seven horses per group averaging 216.5 kg/m²) and three groups of horses transported at “moderate” density (10–11 horses per group averaging 345.5 kg/m²). Three low-density and two moderate-density groups had access to six water bowls inserted through the sides of the compartments during 1-hour rest stops occurring after 8 hours and at the end of transport. Twelve cameras, one mounted in each corner of the three compartments, were used to record behavior. Distance and rate of movement by individual horses during transport and during two 1-hour rest periods were determined by analysis of 206 hours of usable video footage of individual horses. Mean movement rate tended to be higher during travel (4.23 m/hour) than during the 1-hour periods when the truck was stopped (2.75 m/hour), but it did not seem to be influenced by group density. Movement was stimulated by the availability of water during the rest stops. In general, movement was strongly influenced by one or two horses causing disruption of the group, and not by independent actions of members of the group.     

Cardiac Power Output during Dobutamine Stress Test in Horses

Although echocardiography has greatly improved the diagnostic possibilities in equine medicine, determining the prognosis remains a difficult task. In humans, maximal cardiac power output (CPO) has been described as a powerful indicator of exercise capability and outcome in heart disease. The aim of the study is to describe the measurement of CPO by echocardiography and by thermodilution in healthy horses. Six healthy horses were studied. Cardiac output (CO) was measured by thermodilution and Doppler echocardiography at rest and during a pharmacologic stress test consisting of 35 μg/kg atropine followed by incremental steps 2, 4, 6, and 8 μg/kg/min of dobutamine infusion. Mean arterial pressure (MAP) was measured invasively by a catheter introduced into the transverse facial artery. CPO was calculated as the product of CO and MAP. Baseline CPO measured by thermodilution and by Doppler echocardiography was 10.7 ± 3.3 and 13.7 ± 4.5 watts, respectively. CPO increased significantly with pharmacologic stimulation and reached maximal CPO of 66.4 ± 3.6 and 60.4 ± 5.1 watts when measured by thermodilution and Doppler echocardiography, respectively. This study describes an estimation of CPO in horses. Further studies should demonstrate the usefulness of CPO as a predictive indicator in horses suffering from cardiac disease.